FDA Investigator Theodore N Sietsema
Theodore N Sietsema has conducted inspections on 176 sites in 3 countries as of 12 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
176
Last Inspection Date:
12 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland,
United States of America,
Poland
FDA Investigators that have inspected at least one site in common with Theodore N Sietsema:
Adam M True,
Alexandra A Carrico,
Amina Bashir,
Ana E Morales,
Anthony R Petriella,
Antonio M Hampton,
Azza Talaat,
Bei Y He,
Benjamin J Smith,
Bernard P Heidt,
Bing Lin,
Bleta Vuniqi,
Brandi N Mcgrady,
Brian J Davis,
Brian J Mundo,
Brian M Campbell,
Brian P Hendrickson,
Brian P Putz,
Brittany A Mckenzie,
Byron Ho, DVM,
Byron S Beerbower,
Calvin K Cook,
Carla V Jordan,
Caroline H Le,
Catherine D Djordjevic,
CDR Kimberly Y Martin,
Charles L Zhou,
Chase S Baldwin,
Chelsea J Falkowski,
Chelsea J Snider,
Christi L Bellmore,
Constantin Y Philopoulos,
Corrine M Carter,
Courtney E Hillier,
Crystal L Parks,
Daniel B Arrecis,
Daniel J Brown,
Daniel J Gorski,
Danny Tuntevski,
Dariusz Galezowski,
Darren S Morgan,
David A Paterson,
David J Gasparovich,
David M Amy,
David P Moorhead,
Debara R Reese,
Dennis R Downer,
Donald W Myrick,
Douglas C Kovacs,
Edwardstine J Reese,
Elizabeth J Rigoni,
Elizabeth P Mayer,
Emest F Bizjak,
Emily E Krumel,
Emily J Orban,
Eric E Joneson,
Eric S Pittman,
Erin M Miller,
Evan M Kupper,
Geneve M Maxwell,
Geneve M Parks,
George G Calafactor,
Glenn S Quintanilla,
Hassan Ali,
Hassan M Fakhreddine,
Hokenson,
Ifueko Osemwota,
Jacob A Clark,
James A Lane,
James N Rench,
James P Stallings,
Jayne E Holcomb,
Jeffrey D Meng,
Jennifer A Downie,
Jennifer R Johnson,
Jessica E Hensley,
John N Woodall,
Joie A Navarrete,
Joseph A Piechocki,
Joseph M Hudak,
Joseph R Strelnik,
Julia A Avery,
Justin R Hays,
Kathleen M Adams,
Kathryn A Cutajar,
Kathryn A Guardiola,
Kathryn G Brown,
Kayla D Smith,
Kelley L Clark,
Kelly A Sparks,
Kristina Mezin,
Kristina Nastovski,
Larry K Austin,
Laureen F Kononen,
Lauren E Burke,
Lauren E Sexton,
Leslie A Paul,
Liliya R Robertson,
Liliya V Bubiy,
Linda S Jozefiak,
Lisa J Joseph,
Lisa J Renick,
Lisa M Thursam,
Logan M Ebeling,
LT Danielle S Mills,
LT Skip A Payne,
Lyle Wajda,
Margaret N Persich,
Mark G Peterson,
Marlon K Turner,
Martha Sullivan Myrick,
Martin R Vowell,
Matt D Suedkamp,
Matthew J Gretkierewicz,
Matthew R Buenconsejo,
Meisha R Sampson,
Meisha Waters,
Michael A Moutray,
Michael Y Philopoulos,
Michele L Forster, PhD,
Michelle L Jones,
Micmarie Ramos Rodriguez,
Mikhail V Ovanesov, PhD,
Minerva Rivera,
Misty D Harvey,
Mobin A Tawakkul,
Myra K Casey,
Natalie A Guidry,
Neal D Singletary, PhD,
Nelson A Rodriguez,
Nicholas E Boyd,
Nicole S Williams,
Owens,
Pablo Alcantara,
Pamela J Weaver,
Parul M Patel,
Patrick E Gainer,
Patsy J Domingo,
Peyton B Greenwood,
Rafeeq A Habeeb,
Rasha Bamieh,
Rebecca E Dombrowski,
Robert G Taylor,
Robert K Linn,
Robert M Barbosa,
Roger A Hartman,
Rohn R Robertson,
Roshni J Patel,
Ryan J Benedict,
Said H Muse,
Samuel W Labinjo,
Sarah M Napier,
Sarah Nwandiuko,
Sargum C Sood,
Shana L Williams,
Sonya M Lambkin,
Suyang Qin,
Tamayo C Barnes,
Thursaml,
Tonnie L Carter,
Tracey Asinjen Wiersma,
Tracey L Siebesma,
Travis S Bradley,
Twana R Chandler,
Vera M Anderson,
Vesa Vuniqi,
Victoria A Murray,
Wendy M Stark,
William D Tingley,
William G Nelson,
William R Brubaker
Theodore N Sietsema's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2018 | FDA 483 | Mead Johnson & Company, LLC - Form 483, 2018-08-09 |
May, 2019 | FDA 483 | Tower Laboratories Ltd - Form 483, 2019-05-02 |
April, 2017 | FDA 483 | Rest In Peace Farms LLC - Form 483, 2017-04-04 |
February, 2016 | FDA 483 | Saranac Brand Foods, Inc. - Form 483, 2016-02-09 |
November, 2017 | FDA 483 | Saranac Brand Foods, Inc. - Form 483, 2017-11-29 |
March, 2016 | EIR | Mead Johnson & Company, LLC - EIR, 2016-03-10 |
September, 2015 | EIR | Abbott Laboratories - EIR, 2015-09-16 |
December, 2013 | EIR | Abbott Laboratories - EIR, 2013-12-03 |
May, 2018 | EIR | Mead Johnson & Company, LLC - EIR, 2018-05-04 |
August, 2018 | EIR | Mead Johnson & Company, LLC - EIR, 2018-08-09 |
November, 2019 | EIR | Lakeshore Technologies LLC - EIR, 2019-11-19 |
March, 2019 | FDA 483 | Hello Life, Inc. - Form 483, 2019-03-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more